Revolution Medicines, Inc. is 18.2x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($30.65 B vs $1.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IOVA | RVMD |
|---|---|---|
| Market cap | $1.69 B | $30.65 B |
| US-listed rank | #2226 | #454 |
| Revenue (latest FY) | $263.50M | $0.00 |
| Net income (latest FY) | -$391.00M | -$1.13B |
| Net margin | -148.4% | - |
| SEC filings | 1,005 | 782 |
Revolution Medicines, Inc. is 18.2x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($30.65 B vs $1.69 B).
In their latest fiscal years, IOVANCE BIOTHERAPEUTICS, INC. reported $263.50M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: IOVANCE BIOTHERAPEUTICS, INC. and Revolution Medicines, Inc., or browse the full rankings.